A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the Treatment of Seasonal allergies
- Conditions
- Seasonal allergic rhinitis (SAR)Therapeutic area: Body processes [G] - Immune system processes [G12]
- Registration Number
- EUCTR2015-004885-27-Outside-EU/EEA
- Lead Sponsor
- GlaxoSmithKline Research & Development Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- A
- Sex
- All
- Target Recruitment
- 936
- Informed consent.
- Outpatient.
- Females of child-bearing potential must use appropriate contraception.
- Diagnosis of seasonal allergic rhinitis to mountain cedar.
- Adequate exposure to allergen.
- Able to comply with study procedures.
- Literate.
Are the trial subjects under 18? yes
Number of subjects for this age range: 81
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 831
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 24
- Significant concomitant medical condition.
- Use of corticosteroids, allergy medications, or other medication that affect allergic rhinitis
- Positive pregnancy test.
- Allergy to any component of the investigational product.
- Tobacco use
- Contact lens use
- Has chickenpox or measles or recent exposure
- Other clinical trial drug exposure in last 30 days
- Affiliation with clinic site
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method